Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study

[1]  W. White,et al.  Circadian blood pressure: clinical implications based on the pathophysiology of its variability. , 2007, Kidney international.

[2]  H. Volk,et al.  Reduced monocyte CD86 expression in postinflammatory immunodeficiency , 2007, Critical care medicine.

[3]  H. Volk,et al.  A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity , 2007, Journal of hypertension.

[4]  Daniel T. Fisher,et al.  Fever-range thermal stress promotes lymphocyte trafficking across high endothelial venules via an interleukin 6 trans-signaling mechanism , 2006, Nature Immunology.

[5]  T. Kündig,et al.  Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults. , 2006, The Journal of allergy and clinical immunology.

[6]  Yutaka Imai,et al.  Prognostic Significance for Stroke of a Morning Pressor Surge and a Nocturnal Blood Pressure Decline: The Ohasama Study , 2006, Hypertension.

[7]  L. Osterberg,et al.  Adherence to medication. , 2005, The New England journal of medicine.

[8]  G. Jennings,et al.  A therapeutic vaccine for nicotine dependence: preclinical efficacy, and phase I safety and immunogenicity , 2005, European journal of immunology.

[9]  M. Braun,et al.  Postlicensure safety surveillance for 7-valent pneumococcal conjugate vaccine. , 2004, JAMA.

[10]  K. Asadullah,et al.  IL-22 increases the innate immunity of tissues. , 2004, Immunity.

[11]  W. White,et al.  Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period. , 2004, American journal of hypertension.

[12]  A. Stanton,et al.  Blood Pressure Lowering in Essential Hypertension With an Oral Renin Inhibitor, Aliskiren , 2003, Hypertension.

[13]  Morris J. Brown,et al.  Randomized double-blind placebo-controlled study of an angiotensin immunotherapeutic vaccine (PMD3117) in hypertensive subjects. , 2003, Clinical science.

[14]  W. Elliott,et al.  The Economic Impact of Hypertension , 2003, Journal of clinical hypertension.

[15]  Kazuomi Kario,et al.  Morning Surge in Blood Pressure as a Predictor of Silent and Clinical Cerebrovascular Disease in Elderly Hypertensives: A Prospective Study , 2003, Circulation.

[16]  G. Nguyen,et al.  Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. , 2002, The Journal of clinical investigation.

[17]  H. HogenEsch,et al.  Mechanisms of stimulation of the immune response by aluminum adjuvants. , 2002, Vaccine.

[18]  E. Granieri,et al.  Circadian variability in hemorrhagic stroke. , 2002, JAMA.

[19]  H. Volk,et al.  Impaired antigen presentation by human monocytes during endotoxin tolerance , 2000 .

[20]  P. Stone,et al.  Circadian variation and triggers of onset of acute cardiovascular disease. , 1989, Circulation.

[21]  Miller,et al.  of Tissues , 2003 .

[22]  M. Burnier,et al.  Long-term compliance with antihypertensive therapy: another facet of chronotherapeutics in hypertension. , 2000, Blood pressure monitoring.

[23]  V. Mooser,et al.  Rapid measurement of total and active renin: plasma concentrations during acute and sustained converting enzyme inhibition with CGS 14824A. , 1987, Clinical and experimental hypertension. Part A, Theory and practice.